Pitfalls and Safeguards in Industry-Funded Research

Abstract

Background: Physicians should follow ethical principles in their relationships with industry and be mindful that such relationships-if they are perceived as conflicts of interest-can undermine trust in the patient-physician relationship. Methods: By identifying potential pitfalls and safeguards that can help prevent problems, this article focuses on ensuring that physician-industry relationships do not result in ethical transgressions or cause damage to doctor-patient relationships. Results: Patient trust in physicians can be undermined by the perception that a physician-investigator is operating in the best interest of the research rather than the best interest of the patient. Payments from the pharmaceutical industry to physicianinvestigators are transparent because of the Sunshine Act, and patients can easily determine if their personal physicians have received money from industry. Research subsidies from industry should represent fair market value for the work performed. Postmarketing trials with the primary goal of increasing familiarity with a drug and prescribing rates should be avoided. Medical societies play an important role in establishing standards for professional conduct. Conclusion: Ethically sound actions in physician relationships with industry should be guided by professional standards, medical society guidelines, and local institutional policies.

Pro-Con Debate: Interdisciplinary Perspectives on Industry-Sponsored Research

“…27 Appropriate safeguards are needed to ensure that research addresses the most important and relevant questions, that results are available even when they do not support the use of a product produced by the funding company, that populations studied reflect those of the patients we treat, that the most rigorous approaches are applied, that studies have the appropriate power to address the question posed, and that conclusions are presented in an unbiased manner. 28,29 To address these concerns, the FDA has been providing increasingly detailed guidance for industry to conduct clinical trials. Furthermore, journal editors have elevated the reporting standard to increase the rigor and transparency of the research being published.…”

Rules of engagement: Promoting academic-industry partnership in the era of digital pathology and artificial intelligence

“…There are myriad reasons why an AIP may fail including conflict between stakeholders, overpromising, over/under budgeting, unclear or changing aims, poor communication, inadequate governance, lack of a troubleshooting mechanism, milestones not met, failed deliverables, loss of marketability and/or commercialization, and an undesirable scandal. 55 , 56 , 57 , 58 …”

Perception of Older Thai Adults in a Do-Not-Attempt Resuscitation Order during the COVID-19 Era If Infected with COVID-19

“…A do-not-attempt resuscitation (DNR) order is a legal order that allows natural death. 4 , 5 Steinhauser et al 5 found that >90% of patients perceive that at the end of life, individuals need freedom from pain, freedom from shortness of breath, freedom from anxiety, and freedom to be treated as a whole person.…”